FDA OKs New Drug to Slow Breast Cancer
US regulators approved a new drug that in clinical trials delayed breast cancer progression in women no longer responding to trastuzumab (Herceptin), a drug effective against tumors with too much of a protein called HER-2. When given in combination with chemotherapy, the...